Cerca | SocioMint

Atess Karahan ha aggiunto una foto Altre informazioni
2026-07-29 08:37:06 -

Neurofibromatosis Market Share Analysis and Industry Insights
"According to the latest report published by Data Bridge Market Research, the Neurofibromatosis Market The global neurofibromatosis market size was valued at USD 14.60 billion in 2024 and is expected to reach USD 36.66 billion by 2032, at a CAGR of 12.20% during the forecast period Neurofibromatosis Market report contains most-detailed market segmentation, systematic analysis of...

0 Commenti 0 condivisioni 26 Views 0 Anteprima

Effettua l'accesso per mettere mi piace, condividere e commentare!
Surbhi Verma ha aggiunto una foto Health
2026-07-10 10:32:21 -

MEK Inhibitors Market: How Is Neurofibromatosis Type 1 Approval Creating a New Rare-Disease Revenue Stream?
MEK inhibitors targeting neurofibromatosis type 1-associated plexiform neurofibromas — the oral allosteric MEK1/2 inhibitors selumetinib (Koselugo, AstraZeneca) and mirdametinib (Gomekli, SpringWorks Therapeutics) approved for pediatric and adult NF1 patients with symptomatic, inoperable tumors — represent the fastest-growing indication segment in the MEK inhibitor market, with the...

0 Commenti 0 condivisioni 190 Views 0 Anteprima

Effettua l'accesso per mettere mi piace, condividere e commentare!

SocioMint https://sociomint.com